Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

6.74EUR
4:35pm BST
Change (% chg)

€0.22 (+3.37%)
Prev Close
€6.52
Open
€6.60
Day's High
€6.74
Day's Low
€6.46
Volume
30,130
Avg. Vol
35,779
52-wk High
€17.13
52-wk Low
€5.61

About

Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The... (more)

Overall

Beta: 1.39
Market Cap(Mil.): €116.95
Shares Outstanding(Mil.): 17.94
Dividend: --
Yield (%): --

Financials

  ERYP.PA Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -- -- --
ROI: -- 7.41 11.59
ROE: -- 7.88 16.33

BRIEF-Erytech Pharma Presents New Erymethionase Preclinical Findings

* ERYTECH SAID ON MONDAY IT PRESENTED NEW ERYMETHIONASE PRECLINICAL FINDINGS AT 2019 AACR ANNUAL MEETING

02 Apr 2019

BRIEF- Erytech Pharma FY Total Operating Loss Widens To 43.6 Million Euros

* ANNOUNCED ON MONDAY, ERYTECH PROVIDES BUSINESS UPDATE AND REPORTS FINANCIAL RESULTS FOR FULL YEAR 2018

12 Mar 2019

Earnings vs. Estimates